title: [48-hour continuous infusion of vindesine (followed by cisplatin) in advanced lung cancer. Chronopharmacokinetic data and clinical efficacy].
authors.affiliation: Clinique Saint-Joseph-Sainte-Elisabeth, Liège, Belgique.
authors.forename: C
authors.initials: C
authors.lastname: Focan
authors.forename: L
authors.initials: L
authors.lastname: Doalto
authors.forename: V
authors.initials: V
authors.lastname: Mazy
authors.forename: F
authors.initials: F
authors.lastname: Levi
authors.forename: B
authors.initials: B
authors.lastname: Bruguerolle
authors.forename: J P
authors.initials: JP
authors.lastname: Cano
authors.forename: R
authors.initials: R
authors.lastname: Rahmani
authors.forename: B
authors.initials: B
authors.lastname: Hecquet
mesh_terms: D000328:Adult; D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D002940:Circadian Rhythm; D002945:Cisplatin / Q000008:administration & dosage* / Q000493:pharmacokinetics / Q000627:therapeutic use; D004341:Drug Evaluation; D005260:Female; D006801:Humans; D008175:Lung Neoplasms / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D014751:Vindesine / Q000008:administration & dosage* / Q000493:pharmacokinetics / Q000627:therapeutic use
chemical_list: D002945:Cisplatin; D014751:Vindesine
vernacular_title: Vindésine en perfusion continue de 48 heures (suivie de cisplatine) dans le cancer pulmonaire avancé. Données chronopharmacocinétiques et efficacité clinique.